Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric M Mukherjee

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 21, 2022
Where to place etanercept and combination treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis?Eric M Mukherjee, Elizabeth J Phillips
The Yale Journal of Biology and Medicine|November 26, 2015
Tailoring the Treatment of Melanoma: Implications for Personalized MedicineLinna Duan, Eric M Mukherjee, Deepak Narayan
JCI Insight|May 5, 2017
Stat3 regulates desmoglein 3 transcription in epithelial keratinocytesXuming Mao, Michael Jeffrey T Cho, Christoph T Ellebrecht, et al.
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Characterization of Demographics, Drug Latency, and Mortality of Severe Cutaneous Adverse Reactions in an FDA Pharmacovigilance DatabaseEric M Mukherjee, Dodie Park, Matthew S Krantz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 8, 2026
A Multidisciplinary Approach to Checkpoint Inhibitor Adverse ReactionsCourtney N Andrews, Eric M Mukherjee, Andrew Gibson, et al.
Cell Reports|August 30, 2018
Autoreactive IgG and IgA B Cells Evolve through Distinct Subclass Switch Pathways in the Autoimmune Disease Pemphigus VulgarisChristoph T Ellebrecht, Eric M Mukherjee, Qi Zheng, et al.
Plos One|June 16, 2016
Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus VulgarisAgnes S Lo, Xuming Mao, Eric M Mukherjee, et al.
The Journal of Investigative Dermatology|May 22, 2026
Clonal cytotoxic CD8<sup>+</sup> T cell expansion and HLA-B44 supertype association in bupropion-induced severe cutaneous adverse reactionsEric Alves, Ramesh Ram, Eric M Mukherjee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2016
Determinants of VH1-46 Cross-Reactivity to Pemphigus Vulgaris Autoantigen Desmoglein 3 and Rotavirus Antigen VP6Michael Jeffrey Cho, Christoph T Ellebrecht, Christoph M Hammers, et al.
Cell Reports|January 5, 2017
Proteomic Analysis of Pemphigus Autoantibodies Indicates a Larger, More Diverse, and More Dynamic Repertoire than Determined by B Cell GeneticsJing Chen, Qi Zheng, Christoph M Hammers, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 21, 2022
Where to place etanercept and combination treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis?Eric M Mukherjee, Elizabeth J Phillips
The Yale Journal of Biology and Medicine|November 26, 2015
Tailoring the Treatment of Melanoma: Implications for Personalized MedicineLinna Duan, Eric M Mukherjee, Deepak Narayan
JCI Insight|May 5, 2017
Stat3 regulates desmoglein 3 transcription in epithelial keratinocytesXuming Mao, Michael Jeffrey T Cho, Christoph T Ellebrecht, et al.
Medrxiv : the Preprint Server for Health Sciences|March 17, 2025
Characterization of Demographics, Drug Latency, and Mortality of Severe Cutaneous Adverse Reactions in an FDA Pharmacovigilance DatabaseEric M Mukherjee, Dodie Park, Matthew S Krantz, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 8, 2026
A Multidisciplinary Approach to Checkpoint Inhibitor Adverse ReactionsCourtney N Andrews, Eric M Mukherjee, Andrew Gibson, et al.
Cell Reports|August 30, 2018
Autoreactive IgG and IgA B Cells Evolve through Distinct Subclass Switch Pathways in the Autoimmune Disease Pemphigus VulgarisChristoph T Ellebrecht, Eric M Mukherjee, Qi Zheng, et al.
Plos One|June 16, 2016
Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus VulgarisAgnes S Lo, Xuming Mao, Eric M Mukherjee, et al.
The Journal of Investigative Dermatology|May 22, 2026
Clonal cytotoxic CD8<sup>+</sup> T cell expansion and HLA-B44 supertype association in bupropion-induced severe cutaneous adverse reactionsEric Alves, Ramesh Ram, Eric M Mukherjee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2016
Determinants of VH1-46 Cross-Reactivity to Pemphigus Vulgaris Autoantigen Desmoglein 3 and Rotavirus Antigen VP6Michael Jeffrey Cho, Christoph T Ellebrecht, Christoph M Hammers, et al.
Cell Reports|January 5, 2017
Proteomic Analysis of Pemphigus Autoantibodies Indicates a Larger, More Diverse, and More Dynamic Repertoire than Determined by B Cell GeneticsJing Chen, Qi Zheng, Christoph M Hammers, et al.
Pageof 2